We have located links that may give you full text access.
Development of optically sensitive liver cells.
Tissue & Cell 2018 June
Optogenetics is a new and emerging field that involves techniques of optics and genetic engineering to influence cellular functionality. In this work, we have successfully incorporated a non-selective cationic channel channelrhodopsin-2 (ChR2) into human hepatocellular carcinoma (HepG2) cells. A plasmid construct AAV-CAG-ChR2-GFP was used for liposomal transfection into the cells. ChR2 is a light sensitive membrane channel that opens upon illumination with blue light. Plasmid DNA isolation from E. coli XL 10 gold bacteria by alkaline lysis method resulted in a DNA concentration of 1150 μg/mL. A significant difference (p < 0.05) was observed between the fluorescent intensities of transfected cells and the control. The percentage of transfected cells was estimated to be 41.26%. Overall, the study delivers an optimized methodology to produce the transfected HepG2 cells that can be controlled with the light stimulation. Although ChR2 has mostly been associated with excitable cells, we anticipate that its presence into HepG2 cells may also result changes in biological functionalities by modulating the concentration of cations inside the cell. Furthermore, the transfected HepG2 cells can be co-cultured with fibroblasts such as NIH 3T3 to form liver spheroids that can serve as models for toxicological and pharmacological studies.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app